---
document_datetime: 2023-09-21 19:31:14
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/firdapse-epar-all-authorised-presentations_en.pdf
document_name: firdapse-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6553065
conversion_datetime: 2025-12-24 16:58:38.897643
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU)-number   | (invented) name   | Strength   | Pharmaceutical form   | Route of Administration   | Immediate Packaging                        |   Content (concentration) |   Packsize |
|------------------|-------------------|------------|-----------------------|---------------------------|--------------------------------------------|---------------------------|------------|
| EU/1/09/601/001  | Firdapse          | 10 mg      | tablet                | Oral use                  | Perforated unit dose thermoformed blisters |                        10 |        100 |